Large-scale public data reuse to model immunotherapy response and resistance

Jingxin Fu; Karen Li; Wubing Zhang; Changxin Wan; Jing Zhang; Peng Jiang; X. Shirley Liu

doi:10.1186/s13073-020-0721-z

Keywords

ImmunotherapyImmune checkpointMedicineComputational biologyCRISPRBioinformaticsImmune systemComputer scienceBiologyImmunologyGene

Affiliated Institutions

Related Publications

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Golnaz Morad , Beth A. Helmink , Padmanee Sharma +1 more

Unprecedented advances have been made in cancer treatment with the use of immune checkpoint blockade (ICB). However, responses are limited to a subset of patients, and immune-re...

2021 Cell 1455 citations

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

Valsamo Anagnostou , Kellie N. Smith , Patrick M. Forde +26 more

Abstract Immune checkpoint inhibitors have shown significant therapeutic responses against tumors containing increased mutation-associated neoantigen load. We have examined the ...

2016 Cancer Discovery 853 citations

Exomics and immunogenics

Stéphane Champiat , Charles Ferté , Sophie Lebel‐Binay +2 more

Anti-PD-1/PD-L1 antibodies are emerging as promising anticancer therapeutics. Interestingly, elevated response rates to these agents are mostly documented among patients with tu...

2014 OncoImmunology 187 citations

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

Kirsty Brown , Hena R. Ramay , Seungil Paik +10 more

Inosine modulates antitumor immunity Checkpoint blockade immunotherapy harnesses the immune system to kill cancer cells and has been used with great success to treat certain tum...

2020 Science 1160 citations

Immune checkpoint signaling and cancer immunotherapy

Xing He , Chenqi Xu

Abstract Immune checkpoint blockade therapy has become a major weapon in fighting cancer. Antibody drugs, such as anti-PD-1 and anti-PD-L1, demonstrate obvious advantages such a...

2020 Cell Research 1257 citations

Publication Info

Year: 2020
Type: article
Volume: 12
Issue: 1
Pages: 21-21
Citations: 1087
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Large-scale public data reuse to model immunotherapy response and resistance

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1087

OpenAlex

Cite This

APA Style

                            
                                
                                    Jingxin Fu, 
                                
                                    Karen Li, 
                                
                                    Wubing Zhang
                                
                                et al.
                            
                            (2020). 
                            Large-scale public data reuse to model immunotherapy response and resistance. 
                            Genome Medicine
                            , 12
                            (1)
                            , 21-21.
                            https://doi.org/10.1186/s13073-020-0721-z
                        

Identifiers

DOI: 10.1186/s13073-020-0721-z